Three patients with idiopathic orthostatic (postural) hypotension were infused over a 4-hr period with 104.6 ,uc of 3-hydroxytyramine-2-'4C, the immediate precursor in the synthesis of the sympathetic neurohormone, that is, noradrenaline (norepinephrine). Urine was collected during the infusion period and at various intervals thereafter for a total of 5 days. By means of column fractionation, the various metabolic products of hydroxytyramine, including endogenous noradrenaline and its metabolic products, were separated, identified, and their radioactivity measured.
SUMMARY
Three patients with idiopathic orthostatic (postural) hypotension were infused over a 4-hr period with 104.6 ,uc of 3-hydroxytyramine-2-'4C, the immediate precursor in the synthesis of the sympathetic neurohormone, that is, noradrenaline (norepinephrine). Urine was collected during the infusion period and at various intervals thereafter for a total of 5 days. By means of column fractionation, the various metabolic products of hydroxytyramine, including endogenous noradrenaline and its metabolic products, were separated, identified, and their radioactivity measured.
From the comparison of the hydroxytyramine metabolic pattern of normal subjects to that of idiopathic orthostatic hypotensive patients, it was apparent that the greatest changes occurred in the formation of noradrenaline and 3-methoxy-4-hydroxymandelic acid (MOMA, VMA). The synthesis of noradrenaline was significantly reduced in the hypotensive patients, and there was also a marked reduction in the formation of MOMA, the principal metabolic product of noradrenaline. The implication of these findings is that the pathogenesis of idiopathic orthostatic hypotension is related to a defect in the neurogenic structures involved in the biosynthesis of noradrenaline. This conclusion is further supported by the fact that one of the subjects (M.Q.) at autopsy showed only degenerative changes in the sympathetic ganglia and neurons. Additional Indexing Words: Metabolic products of bydroxytyramine (dopamine) Degeneration of sympathetic ganglia and neurons SINCE Bradbury and Eggleston's original description of orthostatic hypotension,l there have been many reports and reviews on this subject.2-9 A number of investigators have postulated the involvement of the sympathetic nervous system3-9; however, it was not until the work of Luft and von Euler,10 and later others,11 12 that a more direct indication of sympathetic nerve involvement became evident. Subsequently, we'2 showed From the Departments of Surgery and Physiology, University of Texas Medical School, Galveston, Texas, and Department of Medicine, Medical College of Virginia, Richmond, Virginia. Work was supported by Grant that despite the marked decrease in the urinary output of this sympathetic neurohormone, patients with chronic orthostatic hypotension metabolized normally the circulating noradrenaline (norepinephrine). Furthermore, these studies suggested that decreased excretion of noradrenaline was probably related to a loss of the neurogenic tissues involved in the synthesis of noradrenaline. 12 In view of these latter findings, it was decided that the same patients should be infused with a labeled noradrenaline precursor, that is, 3-hydroxytyramine-2-14C (3, 4-dihydroxyphenylethylamine, dopamine) in order to determine whether the decrease in urinary output of noradrenaline was related to a decrease in noradrenaline synthesis.
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Methods
Three patients with idiopathic orthostatic hypotension were studied. The clinical findings of each patient are summarized in table 1. Two or more 24-hr urine samples were collected from each patient and bioassayed for adrenaline and noradrenaline.12 13 The results of these findings are summarized in table 2. Each patient was infused with 104.6 ,uc (872 ,ug) of 3-hydroxytyramine-2-14C (3, 4-dihydroxyphenylethylamine, dopamine).* The labeled hydroxytyramine was dissolved in 1,000 ml of physiological saline and infused via the antecubital vein at a constant rate, over a period of 4 hr. The subjects were kept supine during the infusion and maintained in a sedentary state during the collection periods. Urine was collected during the infusion period and at 2-hr intervals for the first 4 hr postinfusion, then at the end of 8 hr, 24 hr, and at the end of the second, third, fourth, and fifth days. The urine samples were frozen immediately and stored at -20 C until assayed.
The method for isolating and quantifying endogenous noradrenaline and the metabolic products of noradrenaline, as well as the metabolic products of hydroxytyramine, has been previously described.14 In brief, it is as follows:
Separation of Acidic Compounds
An aliquot of urine containing 100,000 dpm to which was added carrier compounds of 3methoxy-4-hydroxymandelic acid (MOMA), 3- included degeneration of sympathetic nerves and replacemethoxy-4-hydroxyphenylacetic acid (HVA), 3, 4-dihydroxymandelic acid (DOMA) and 3, 4dihydroxyphenylacetic acid (DOPAC) was placed on a 1 by 35-cm column of Dowex-I-X2t acetate anion exchange resin. The column was placed on an automatic fraction collection system and eluted with a gradient elution consisting of 250 ml of H20 and 250 ml of 0.01 M ammonium acetate, pH 4.0 followed by a variable gradient elution consisting of ammonium acetate buffers of varying molarity and acidity. The flow rate was adjusted to approximate 1 ml/min. spectrophotometer,t and the optical density was measured at 279 mu. The output of the DB-G spectrophotometer was recorded on one channel of a dual-pen recorder. After passing through the DB-G spectrophotometer, the eluate entered a 10-ml flow cell and the radioactivity was counted with a specially developed flow system, that is, Packard experimental,t analog, digital flow system. The output was recorded on the other channel of the dual recorder. From the fraction collector, an impulse was relayed to an event marker on the recorder so as to indicate the change of each fraction by the fraction collector. Those fractions comprising a single radioactivity peak were pooled and assayed for total radioactivity. Figure 1 represents a typical elution pattern obtained with this system.
The recovery of the total radioactivity placed on the Dowex-1 column was 97 + 6%. The peaks containing specific free phenolic acids, such as MOMA, HVA, DOMA, and DOPAC, were confirmed by paper chromatography of each peak in three solvent systems, that is, n-butanol-Nacetic acid-H20 (4:1:1), benzene-proprionic acid-H20 (8:2:2) and isopropanol-5% NH3 (8:2); in order to chromatograph these peaks, it was necessary to first remove the ammonium acetate. The conjugates of HVA, MOMA, and DOPAC were identified by refluxing the ammonium acetate free peak in 3N-H2SO4 followed by extraction into ether and chromatography of the resulting compound with appropriate carrier compounds in the solvent systems described above. The conjugates of 3-methoxytyramine 3-HT) were identified by hydrolysis of the conjugated amine in 2N-H2SO4 followed by ion exchange absorption and chromatography of the free amines on IRC-50 Amberlite resin.* The peak containing the normetadrenaline conjugate was also found to contain significant amounts of noradrenaline conjugate. The various acidic and basic metabolites are compiled and compared to those of normal subjects in tables 3 and 4.
Separation of the Basic Compounds
An aliquot of urine containing 500,000 dpm was placed on a 60 by 0.9 cm column of Amberlite IRC-50 resin along with carrier compounds of adrenaline (epinephrine), metadrenaline (3-0-methyladrenaline, metanephrine), normetadrenaline (3-0-methylnoradrenaline, normetanephrine), noradrenaline (norepinephrine), 3-hydroxytyramine (dopamine), and 3-methoxytyramine. The column was washed with 20 ml of 0.2M ammonium acetate buffer pH 6.2 and attached to the flow monitoring system. The column was eluted with 0.3M ammonium acetate buffer pH 5.0 followed by 0.4M buffer. The large radioactive peak at the beginning of the elution which was washed off the column with 0.2M ammonium acetate contained the acidic metabolites. The basic metabolites were eluted from the column with 0.3M and 0.4M ammonium acetate pH 5.0. In postinfusion urines, these basic metabolites represented 1 to 2% of the total radioactivity placed on the column. The identity of the radioactive peaks was determined and confirmed by paper chromatography. Adrenaline and normetadrenaline elute from the column at the same point, but in these experiments further separation procedures did not yield significant amounts of adrenaline. Most of the radioactivity was confined to normetadrenaline, noradrenaline, and 3-hydroxytyramine; only trace amounts of 3-methoxytyramine and adrenaline were found (table 3) . Results
From the results, it is apparent that the greatest changes occur in the formation of noradrenaline and MOMA (3-methoxy-4-hydroxymandelic acid) (tables 3 and 4, figs. 2 and 3). The synthesis of noradrenaline is significantly decreased as reflected by a marked decrease in the radioactive noradrenaline recovered throughout the collection pe-*Amberlite IRC-50 (CG-50, type LI), Rohm and Haas Company, Philadelphia, Pennsylvania. riods (table 3, fig. 2 ). There is also a marked decrease in the formation of MOMA, the principle metabolite of noradrenaline ( fig.  3) ; this too is present in all the collection periods. Concomitant with the decrease in the formation of noradrenaline and its metabolite MOMA, there is a modest increase in the recovery of radioactive hydroxytyramine throughout the first 24 hr after infusion and a modest increase in 3-methoxy-4-hydroxyphenylacetic acid and its conjugate after the 2to 4-hr collection period (tables 3 and 4). Changes in 3, 4-dihydroxyphenylacetic acid were less definitive.
HOURS POST-INFUSION

Figure 2
The accumulative recovery of the infused radioactivity as noradrenaline from the beginning of the infusion of 3-hydroxytyramine-2-14C for 72 hours after infusion. A comparison between normal subjects and three patients with idiopathic orthostatic hypotension. The accumulative recovery of the infused radioactivity as 3-methoxy-4-hydroxymandelic acid (MOMA, VMA) from the beginning of the infusion of hydroxytyramine-2-1-C for 72 hours after infusion. A comparison between normal subjects and three patients with idiopathic orthostatic hypotension. Whereas all patients showed the same general pattern as described above, they, as would be expected, varied in degree from one to the other. In terms of MOMA and DOPAC, patient E.M. showed the least variation from the normal, but still showed a marked decrease in noradrenaline synthesis (tables 3 and 4, figs. 2 and 3).
The amount of radioactivity recovered 120 hr after infusion was 97.2 -+-3.5% in normal subjects and varied between 78.4 and 99.8% in the patients with orthostatic hypotension.
Several unknown metabolic products of hydroxytyramine have been previously described.'4 Some of these unknown metabolic products, that is, peak 6, peak 12, and peak 17, showed alterations in patients with orthostatic hypotension, but since their identity was unknown, the meaning behind this alteration remains obscure (tables 3 and 4).
Discussion
It is generally accepted that noradrenaline is the neurohormone of the sympathetic nerves. [15] [16] [17] Further, it has been suggested that the sympathetic nervous system is involved in the pathogenesis of idiopathic orthostatic hypotension,3-6, 8, 9 however, the mechanisms of involvement have not hitherto been elucidated. The fact that idiopathic orthostatic hypotensive patients consistently show a subnormal urinary output of the sympathetic neurohormone, noradrenaline, clearly implicates the sympathetic nervous system.'0-12 Since the discovery of hydroxytyramine in mammalian tissue'8' 19 and since the sympathetic ganglia and neuron synthesize noradrenaline directly from hydroxytyramine,17, 20, 21 these infusion studies provide
Figure 5
Section of the sympathetic nerve from patient M.Q. Deposits of amyloid and degenerative changes are seen within the nerve causing disruption and replacement of nerve fibers.
Hematoxylin and eosin: X 220. Circulation, Volume XXXVIlI, September 1968 an assessment of noradrenaline synthesis by the sympathetic nerve ( fig. 4) .
Recently, we demonstrated12 that the metabolism of circulating noradrenaline in idiopathic orthostatic hypotension was within normal limits, thereby indicating that an accelerated metabolism of noradrenaline was not responsible for the decrease in the urinary output of noradrenaline. This suggests that the probable defect lies either in a decreased noradrenaline synthesis or decreased release, or both, renal excretion being normal. At least one of the orthostatic hypotensive patients herein described, that is, M.Q., showed degenerative changes in the sympathetic ganglia and neurons ( fig. 5 ) leading to the postulation that there might be a decrease in noradrenaline synthesis by the sympathetic nerves.
Results herein described confirm that there is a marked decrease in the synthesis of noradrenaline; this is reflected by a decline in the urinary recovery of radioactive noradrenaline following an infusion of the immediate precursor to noradrenaline, that is, 3-hydroxytyramine-2-14C (table 3 and fig. 2 ). Further, there was a marked decrease in the formation of 3-methoxy-4-hydroxymandelic acid (MOMA), the principal metabolite of noradrenahne22, 23 (table 4 and fig. 3 ). Whereas, this decrease in MOMA is related to the decrease in the synthesis of noradrenaline, it also could be related to a partial failure in deamination or 0-methylation ( fig. 6 ). Alternate pathways for the metabolism of noradrenaline (norepinephrine). We have previously shown in these same patients that there was no significant impairment in the 0-methylation or deamination of circulating noradrenaline.12 Further, the fact that the methoxytyramine conjugate, 3-methoxy-4-hydroxyphenylacetic acid (free and conjugated) and 3, 4-dihydroxyphenylacetic acid (free and conjugated) were readily formed, again shows that there is no impairment in deamination or 0-methylation of the infused (circulating) hydroxytyramine. Therefore, attention is focused on endogenous noradrenaline, as it relates to the sympathetic nerves, rather than on exogenous or circulating noradrenaline. Many tissues contain amine oxidase and O-methyltransferase,24-38 but 0-methyltransferase is not found intraneurally in the sympathetic nerves.31-33 36 Since MOMA results from the action of both of these enzymes, the question arises as to which of these enzymes are involved in this decreased formation of MOMA. A comparison of the normal 24-hr formation ratio of MOMA from noradrenaline, MOMA from normetadrenaline and normetadrenaline from noradrenaline, to that of the hypotensive patient, it appears there is a significant loss of amine oxidase activity and a small shift towards 0-methylation (tables 3 and 4 5 ) one would then expect a loss of intraneural amine oxidase activity along with the derease in noradrenaline synthesis. The question may arise as to why the urinary output of adrenaline is not also decreased in patients with idiopathic orthostatic hypotension, since adrenaline is synthesized directly from noradrenaline, that is, the N-methylated product of noradrenaline. The probable answer is that in the human, adrenaline is principally formed in the adrenal medulla and since in these patients the Circulation, Volume XXXVIII, September 1968 pathogenesis is related to a degenerative change of the sympathetic nerves and not to any change of the adrenal medulla one would then expect a normal synthesis of adrenaline. In brief, there is no enzyme defect per se, but rather a decrease in the number of functional sympathetic units involved in the synthesis of the sympathetic neurohormone. This would lead to a decrease in synthesis of noradrenaline and therefore a decrease in the urinary output of noradrenaline, but would have no perceptible effect upon the adrenaline synthesis and output.
In view of the fact that the clinical picture and biochemical findings of the patient (M.Q.) with sympathetic degenerative changes ( fig. 5 ) were rather similar to those of the other hypotensive patients this would lead one to conclude that the pathogenesis of idiopathic orthostatic hypotension is probably related to a defect in the neurogenic structures involved in the synthesis of noradrenaline and therefore this syndrome would be more accurately described as being "neurogenic" rather than idiopathic. Growth and Form (1967) This newer conception represents a genuine upheaval of biological thought, and it marks the disappearance of what may be called the colloidal conception of vital organization, itself a sophisticated variant of the older doctrine of 'protoplasm.' The idea of protoplasm as a fragile colloidal slime, a sort of biological ether permeating otherwise inanimate structures, was already obsolete in the 'thirties; even then no one could profess to be studying 'protoplasm' without being thought facetious or slightly mad.... The substitution of the structural for the colloidal conception of 'the physical basis of life' was one of the great revolutions of modern biology; but it was a quiet revolution, for no one opposed it, and for that reason, I suppose, no one thought to read a funeral oration over protoplasm itself. Circulation, Volume XXXVIII, September 1968 
